Pinealon (EDR) Peptide Intelligence Monograph | FIME

Neuroprotection • Oxidative Stress • Hypoxia Biology • Gene Regulation • Cognitive & Aging Research

Pinealon is remarkably simple: just three amino acids—Glu-Asp-Arg (EDR). Yet this tiny peptide has generated intriguing research involving neuronal survival, oxidative stress, hypoxia, gene regulation, cognition, and aging biology.

The FIME Pinealon Peptide Intelligence Monograph examines the experimental science behind this unusual tripeptide, including its reported neuroprotective and antihypoxic effects, proposed gene-regulatory mechanisms, and the evidence surrounding its growing reputation as a cognitive and longevity peptide.

But Pinealon also presents an important scientific problem: much of its evidence originates from a relatively concentrated research lineage, independent replication remains limited, and robust modern human clinical validation is lacking.

We examine both sides—what the experiments genuinely suggest and where commercial claims have traveled beyond the evidence.

Three amino acids. A fascinating hypothesis. A clinical question still waiting to be answered.

Established biology. Emerging science. Unproven therapy.

Version 1.0 Final
Founder’s Institute of Medicine & Education

For professional education and scientific review. Not individualized medical advice, prescribing guidance, cognitive-enhancement guidance, anti-aging guidance, or a treatment protocol.